Pediatric Nephrology

, Volume 25, Issue 4, pp 687–697 | Cite as

Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy

  • Robert L. ChevalierEmail author
  • Barbara A. Thornhill
  • Michael S. Forbes
  • Susan C. Kiley


Congenital obstructive nephropathy accounts for the greatest fraction of chronic kidney disease in children. Genetic and nongenetic factors responsible for the lesions are largely unidentified, and attention has been focused on minimizing obstructive renal injury and optimizing long-term outcomes. The cellular and molecular events responsible for obstructive injury to the developing kidney have been elucidated from animal models. These have revealed nephron loss through cellular phenotypic transition and cell death, leading to the formation of atubular glomeruli and tubular atrophy. Altered renal expression of growth factors and cytokines, including angiotensin, transforming growth factor-β, and adhesion molecules, modulate cell death by apoptosis or phenotypic transition of glomerular, tubular, and vascular cells. Mediators of cellular injury include hypoxia, ischemia, and reactive oxygen species, while fibroblasts undergo myofibroblast transformation with increased deposition of extracellular matrix. Progression of the lesions involves interstitial inflammation and interstitial fibrosis, both of which impair growth of the obstructed kidney and result in compensatory growth of the contralateral kidney. The long-term outcome depends on timing and severity of the obstruction and its relief, minimizing ongoing injury, and enhancing remodeling. Advances will depend on new biomarkers to evaluate the severity of obstruction, to determine therapy, and to follow the evolution of lesions.


Apoptosis Biomarkers Fibrosis Growth factors Inflammation Recovery 


  1. 1.
    Chevalier RL, Peters CA (2003) Congenital urinary tract obstruction: Proceedings of the State-Of-The-Art Strategic Planning Workshop - National Institutes of Health, Bethesda, Maryland, USA, 11–12 March 2002. Pediatr Nephrol 18:576–606PubMedGoogle Scholar
  2. 2.
    Airik R, Kispert A (2007) Down the tube of obstructive nephropathies: the importance of tissue interactions during ureter development. Kidney Int 72:1459–1467PubMedGoogle Scholar
  3. 3.
    Miyazaki Y, Tsuchida S, Nishimura H, Pope JC, Harris RC, McKanna JM, Inagami T, Hogan BM, Fogo A, Ichikawa I (1998) Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102:1489–1497PubMedGoogle Scholar
  4. 4.
    Miyazaki Y, Tsuchida S, Fogo A, Ichikawa I (1999) The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 55:1683–1695PubMedGoogle Scholar
  5. 5.
    Chang CP, McDill BW, Neilson JR, Joist HE, Epstein JA, Crabtree GR, Chen F (2004) Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest 113:1051–1058PubMedGoogle Scholar
  6. 6.
    Pope JC, Brock JW III, Adams MC, Miyazaki Y, Stephens FD, Ichikawa I (2001) Congenital anomalies of the kidney and urinary tract—role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. J Urol 165:196–202PubMedGoogle Scholar
  7. 7.
    Hiraoka M, Taniguchi T, Nakai H, Kino M, Okada Y, Tanizawa A, Tsukahara H, Ohshima Y, Muramatsu I, Mayumi M (2001) No evidence for AT2R gene derangement in human urinary tract anomalies. Kidney Int 59:1244–1249PubMedGoogle Scholar
  8. 8.
    Peters CA (1997) Obstruction of the fetal urinary tract. J Am Soc Nephrol 8:653–663PubMedGoogle Scholar
  9. 9.
    Matsell DG, Tarantal AF (2002) Experimental models of fetal obstructive nephropathy. Pediatr Nephrol 17:470–476PubMedGoogle Scholar
  10. 10.
    Peters CA, Carr MC, Lais A, Retik AB, Mandell J (1992) The response of the fetal kidney to obstruction. J Urol 148:503–509PubMedGoogle Scholar
  11. 11.
    Matsell DG, Mok A, Tarantal AF (2002) Altered primate glomerular development due to in utero-urinary tract obstruction. Kidney Int 61:1263–1269PubMedGoogle Scholar
  12. 12.
    MacDonald MS, Emery JL (1959) The late intrauterine and postnatal development of human renal glomeruli. J Anat 93:331–340PubMedGoogle Scholar
  13. 13.
    Larsson L, Aperia A, Wilton P (1980) Effect of normal development on compensatory renal growth. Kidney Int 18:29–35PubMedGoogle Scholar
  14. 14.
    Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet-Benichou C (1987) Effects of prenatal and postnatal exposure to gentamicin on renal differentiation in the rat. Toxicology 43:301–313PubMedGoogle Scholar
  15. 15.
    Hartman HA, Lai HL, Patterson P (2007) Cessation of renal morphogenesis in mice. Dev Biol 310:379–387PubMedGoogle Scholar
  16. 16.
    Chevalier RL, Forbes MS, Thornhill BA (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75:1145–1152PubMedGoogle Scholar
  17. 17.
    Larsson L, Maunsbach AB (1980) The ultrastructural development of the glomerular filtration barrier in the rat kidney: a morphometric analysis. J Ultrastr Res 72:392–406Google Scholar
  18. 18.
    Chevalier RL, Kim A, Thornhill BA, Wolstenholme JT (1999) Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int 55:793–807PubMedGoogle Scholar
  19. 19.
    Hilgers KF, Nagaraj SK, Karginova EA, Kazakova IG, Chevalier RL, Carey RM, Pentz ES, Gomez RA (1998) Molecular cloning of KS, a novel rat gene expressed exclusively in the kidney. Kidney Int 54:1444–1454PubMedGoogle Scholar
  20. 20.
    Poucell-Hatton S, Huang M, Bannykh S, Benirschke K, Masliah E (2000) Fetal obstructive uropathy: patterns of renal pathology. Pediatr Dev Pathol 3:223–231PubMedGoogle Scholar
  21. 21.
    Tarantal AF, Han VKM, Cochrum KC, Mok A, DaSilva M, Matsell DG (2001) Fetal rhesus monkey model of obstructive renal dysplasia. Kidney Int 59:446–456PubMedGoogle Scholar
  22. 22.
    Chevalier RL, Chung KH, Smith CD, Ficenec M, Gomez RA (1996) Renal apoptosis and clusterin following ureteral obstruction: the role of maturation. J Urol 156:1474–1479PubMedGoogle Scholar
  23. 23.
    Cachat F, Lange-Sperandio B, Chang AY, Kiley SC, Thornhill BA, Forbes MS, Chevalier RL (2003) Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 63:564–575PubMedGoogle Scholar
  24. 24.
    Thornhill BA, Burt LA, Chen C, Forbes MS, Chevalier RL (2005) Variable chronic partial ureteral obstruction in the neonatal rat: a new model of ureteropelvic junction obstruction. Kidney Int 67:42–52PubMedGoogle Scholar
  25. 25.
    Chevalier RL, Thornhill BA, Wolstenholme JT, Kim A (1999) Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 161:309–313PubMedGoogle Scholar
  26. 26.
    Peters CA, Gaertner RC, Carr MC, Mandell J (1993) Fetal compensatory renal growth due to unilateral ureteral obstruction. J Urol 150:597–600PubMedGoogle Scholar
  27. 27.
    Yoo KH, Thornhill BA, Forbes MS, Chevalier RL (2006) Compensatory renal growth due to neonatal ureteral obstruction: implications for clinical studies. Pediatr Nephrol 21:368–375PubMedGoogle Scholar
  28. 28.
    Gasser B, Mauss Y, Ghnassia JP, Favre R, Kohler M, Yu O, Vonesch JL (1993) A quantitative study of normal nephrogenesis in the human fetus: its implication in the natural history of kidney changes due to low obstructive uropathies. Fetal Diagn Ther 8:371–384PubMedGoogle Scholar
  29. 29.
    Rosen S, McClellan D, Huang WY, Borer J, Peters C (2003) The morphology of the kidney in ureteropelvic junction obstruction (abstract). Pediatr Nephrol 18:586–587Google Scholar
  30. 30.
    Snyder HM, Lebowitz RL, Colodny AH, Bauer SB, Retik AB (1980) Ureteropelvic junction obstruction in children. Urol Clin North Am 7:273–290PubMedGoogle Scholar
  31. 31.
    Valayer J, Adda G (1982) Hydronephrosis due to pelviureteric junction obstruction in infancy. Brit J Urol 54:451–454PubMedGoogle Scholar
  32. 32.
    Eskild-Jensen A, Frokiaer J, Djurhuus JC, Jorgensen TM, Nyengaard JR (2002) Reduced number of glomeruli in kidneys with neonatally induced partial ureteropelvic obstruction in pigs. J Urol 167:1435–1439PubMedGoogle Scholar
  33. 33.
    Josephson S (1983) Experimental obstructive hydronephrosis in newborn rats: III. long-term effects on renal function. J Urol 129:396–400PubMedGoogle Scholar
  34. 34.
    Chevalier RL, Thornhill BA, Chang AY, Cachat F, Lackey A (2002) Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis. Kidney Int 61:2033–2043PubMedGoogle Scholar
  35. 35.
    Thornhill BA, Forbes MS, Marcinko ES, Chevalier RL (2007) Glomerulotubular disconnection in neonatal mice after relief of partial ureteral obstruction. Kidney Int 72:1103–1112PubMedGoogle Scholar
  36. 36.
    Garcia CH, Krueger K, Landing BH, Wells TR (1986) Microdissection demonstration of the lesion of the endocrine kidney in children. Pediatr Pathol 5:45–54PubMedGoogle Scholar
  37. 37.
    Konda R, Orikasa S, Sakai K, Ota S, Kimura N (1996) The distribution of renin containing cells in scarred kidneys. J Urol 156:1450–1454PubMedGoogle Scholar
  38. 38.
    Chevalier RL, Forbes MS (2008) Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19:197–206PubMedGoogle Scholar
  39. 39.
    Chevalier RL (2006) Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Prac Nephrol 2:157–168Google Scholar
  40. 40.
    Huang WY, Peters CA, Zurakowski D, Borer JG, Diamond DA, Bauer SB, McLellan DL, Rosen S (2006) Renal biopsy in congenital ureteropelvic junction obstruction: evidence for parenchymal maldevelopment. Kidney Int 69:137–143PubMedGoogle Scholar
  41. 41.
    Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED Jr, Felsen D (2000) Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301–2313PubMedGoogle Scholar
  42. 42.
    Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, Meldrum KK (2005) TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 288:F406–F411PubMedGoogle Scholar
  43. 43.
    Hughes J, Johnson RJ (1999) Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction. Am J Physiol 277:F26–F32PubMedGoogle Scholar
  44. 44.
    Choi YJ, Mendoza L, Rha SJ, Sheikh-Hamad D, Baranowska-Daca E, Nguyen V, Smith CW, Nassar G, Suki WN, Truong LD (2001) Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice. J Am Soc Nephrol 12:983–992PubMedGoogle Scholar
  45. 45.
    Malik RK, Thornhill BA, Chang AY, Kiley SC, Chevalier RL (2001) Renal apoptosis parallels ceramide content following chronic ureteral obstruction in the neonatal rat. Am J Physiol 281:F56–F61Google Scholar
  46. 46.
    Chung KH, Chevalier RL (1996) Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 155:1139–1144PubMedGoogle Scholar
  47. 47.
    Burt LE, Forbes MS, Thornhill BA, Chevalier RL (2007) Renal vascular endothelial growth factor (VEGF) in neonatal obstructive nephropathy: I. Endogenous VEGF. Am J Physiol 292:F158–F167Google Scholar
  48. 48.
    Silverstein DM, Travis BR, Thornhill BA, Schurr JS, Kolls JK, Leung JC, Chevalier RL (2003) Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int 64:25–35PubMedGoogle Scholar
  49. 49.
    Forbes MS, Thornhill BA, Park MH, Chevalier RL (2007) Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am J Pathol 170:87–99PubMedGoogle Scholar
  50. 50.
    Murer L, Benetti E, Centi S, Della VM, Artifoni L, Capizzi A, Zucchetta P, Del PD, Carasi C, Montini G, Rigamonti W, Zaccello G (2006) Clinical and molecular markers of chronic interstitial nephropathy in congenital unilateral ureteropelvic junction obstruction. J Urol 176:2668–2673PubMedGoogle Scholar
  51. 51.
    Han SW, Lee SE, Kim JH, Jeong HJ, Rha KH, Choi SK (1998) Does delayed operation for pediatric ureteropelvic junction obstruction cause histopathological changes? J Urol 160:984–988PubMedGoogle Scholar
  52. 52.
    Valles P, Pascual L, Manucha W, Carrizo L, Ruttler M (2003) Role of endogenous nitric oxide in unilateral ureteropelvic junction obstruction in children. Kidney Int 63:1104–1115PubMedGoogle Scholar
  53. 53.
    Ward RM, Starr NT, Snow BW, Bellinger MF, Pysher TJ, Zaino RJ (1989) Serial renal function in an ovine model of unilateral fetal urinary tract obstruction. J Urol 142:652–656PubMedGoogle Scholar
  54. 54.
    Chevalier RL (1984) Chronic partial ureteral obstruction in the neonatal guinea pig. II: pressure gradients affecting glomerular filtration rate. Pediatr Res 18:1271–1277PubMedGoogle Scholar
  55. 55.
    Lama G, Ferraraccio F, Iaccarino F, Luongo I, Marte A, Rambaldi PF, Esposito-Salsano M (2003) Pelviureteral junction obstruction: correlation of renal cell apoptosis and differential renal function. J Urol 169:2335–2338PubMedGoogle Scholar
  56. 56.
    Winyard PJD, Nauta J, Lirenman DS, Hardman P, Sams VR, Risdon RA, Woolf AS (1996) Deregulation of cell survival in cystic and dysplastic renal development. Kidney Int 49:135–146PubMedGoogle Scholar
  57. 57.
    Kiley SC, Thornhill BA, Tang SS, Ingelfinger JR, Chevalier RL (2003) Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 63:33–42PubMedGoogle Scholar
  58. 58.
    Lange-Sperandio B, Cachat F, Thornhill BA, Chevalier RL (2002) Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 61:516–524PubMedGoogle Scholar
  59. 59.
    Lange-Sperandio B, Fulda S, Vandewalle A, Chevalier RL (2003) Macrophages induce apoptosis in proximal tubule cells. Pediatr Nephrol 18:335–341PubMedGoogle Scholar
  60. 60.
    Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H (2002) Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol 167:1497–1502PubMedGoogle Scholar
  61. 61.
    Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H (2001) Quantification of TGF-β1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol 281:F513–F521Google Scholar
  62. 62.
    Johnson DW, Saunders HJ, Baxter RC, Feld MJ, Pollock CA (1998) Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54:747–757PubMedGoogle Scholar
  63. 63.
    Seseke F, Thelen P, Ringert RH (2004) Characterization of an animal model of spontaneous congenital unilateral obstructive uropathy by cDNA microarray analysis. Eur Urol 45:374–381PubMedGoogle Scholar
  64. 64.
    Liapis H, Doshi RH, Watson MA, Liapis A, Steinhardt GF (2002) Reduced renin expression and altered gene transcript profiles in multicystic dysplastic kidneys. J Urol 168:1816–1820PubMedGoogle Scholar
  65. 65.
    Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341–350PubMedGoogle Scholar
  66. 66.
    Butt MJ, Tarantal AF, Jimenez DF, Matsell DG (2007) Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction. Kidney Int 72:936–944PubMedGoogle Scholar
  67. 67.
    Chung KH, Gomez RA, Chevalier RL (1995) Regulation of renal growth factors and clusterin by angiotensin AT1 receptors during neonatal ureteral obstruction. Am J Physiol 268:F1117–F1123PubMedGoogle Scholar
  68. 68.
    Norwood VF, Carey RM, Geary KM, Jose PA, Gomez RA, Chevalier RL (1994) Neonatal ureteral obstruction stimulates recruitment of renin-secreting renal cortical cells. Kidney Int 45:1333–1339PubMedGoogle Scholar
  69. 69.
    Kawada N, Moriyama T, Ando A, Fukunaga M, Miyata T, Kurokawa K, Imai E, Hori M (1999) Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int 56:1004–1013PubMedGoogle Scholar
  70. 70.
    Pat B, Yang T, Kong C, Watters D, Johnson DW, Gobe G (2005) Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67:931–943PubMedGoogle Scholar
  71. 71.
    Agarwal R (2002) Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol 284:F863–F869Google Scholar
  72. 72.
    Kinter M, Wolstenholme JT, Thornhill BA, Newton EA, McCormick ML, Chevalier RL (1999) Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion. Kidney Int 55:1327–1334PubMedGoogle Scholar
  73. 73.
    Ricardo SD, Ding G, Eufemio M, Diamond JR (1997) Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol 272:F789–F798PubMedGoogle Scholar
  74. 74.
    Chevalier RL, Peach MJ (1985) Hemodynamic effects of enalapril on neonatal chronic partial ureteral obstruction. Kidney Int 28:891–898PubMedGoogle Scholar
  75. 75.
    Beharrie A, Franc-Guimond J, Rodriguez MM, Au J, Zilleruelo G, Abitbol CL (2004) A functional immature model of chronic partial ureteral obstruction. Kidney Int 65:1155–1161PubMedGoogle Scholar
  76. 76.
    McDougal WS (1982) Pharmacologic preservation of renal mass and function in obstructive uropathy. J Urol 128:418–421PubMedGoogle Scholar
  77. 77.
    Chen CO, Park MH, Forbes MS, Thornhill BA, Kiley SC, Yoo KH, Chevalier RL (2007) Angiotensin converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol 292:F946–F955PubMedGoogle Scholar
  78. 78.
    Coleman CM, Minor JJ, Burt LE, Thornhill BA, Forbes MS, Chevalier RL (2007) Angiotensin AT1 receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol 293:F262–F268CrossRefGoogle Scholar
  79. 79.
    Hanss BG, Lewy JE, Vari RC (1994) Alterations in glomerular dynamics in congenital, unilateral hydronephrosis. Kidney Int 46:48–57PubMedGoogle Scholar
  80. 80.
    Yanagisawa H, Morrissey J, Morrison AR, Purkerson ML, Klahr S (1990) Role of ANG II in eicosanoid production by isolated glomeruli from rats with bilateral ureteral obstruction. Am J Physiol 258:F85–F93PubMedGoogle Scholar
  81. 81.
    Hammad FT, Wheatley AM, Davis G (2000) Long-term renal effects of unilateral ureteral obstruction and the role of endothelin. Kidney Int 58:242–250PubMedGoogle Scholar
  82. 82.
    Reyes AA, Martin D, Settle S, Klahr S (1992) EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy. Kidney Int 41:403–413PubMedGoogle Scholar
  83. 83.
    Foxall PJD, Bewley S, Neild GH, Rodeck CH, Nicholson JK (1995) Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy. Arch Dis Child Fetal Neonatal 73:F153–F157Google Scholar
  84. 84.
    Murer L, Addabbo F, Carmosino M, Procino G, Tamma G, Montini G, Rigamonti W, Zucchetta P, della Vella M, Venturini A, Zacchello G, Svelto M, Valenti G (2004) Selective decrease in urinary aquaporin 2 and increase in prostaglandin E2 excretion is associated with postobstructive polyuria in human congenital hydronephrosis. J Am Soc Nephrol 15:2705–2712PubMedGoogle Scholar
  85. 85.
    Claesson G, Svensson L, Robertson B, Josephson S, Cederlund T (1989) Experimental obstructive hydronephrosis in newborn rats. XI. A one-year follow-up study of renal function and morphology. J Urol 142:1602–1607PubMedGoogle Scholar
  86. 86.
    Li C, Wang W, Kwon TH, Isikay L, Wen JG, Marples D, Djurhuus JC, Stockwell A, Knepper MA, Nielsen S, Frokiaer J (2001) Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect. Am J Physiol 281:F163–F171Google Scholar
  87. 87.
    Boubaker A, Prior JO, Meyrat B, Delaloye AB (2003) Unilateral ureteropelvic junction obstruction in children: long-term followup after unilateral pyeloplasty. J Urol 170:575–579PubMedGoogle Scholar
  88. 88.
    Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halperin I, Farkas A (2006) Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol 49:734–739PubMedGoogle Scholar
  89. 89.
    Eskild-Jensen A, Jorgensen TM, Olsen LH, Djurhuus JC, Frokiær J (2003) Renal function may not be restored when using decreasing differential function as the criterion for surgery in unilateral hydronephrosis. BJU Int 92:779–782PubMedGoogle Scholar
  90. 90.
    Chiou YY, Chiu NT, Wang ST, Cheng HL, Tang MJ (2004) Factors associated with the outcomes of children with unilateral ureteropelvic junction obstruction. J Urol 171:397–402PubMedGoogle Scholar
  91. 91.
    Shi Y, Pedersen M, Li C, Wen JG, Thomsen K, Stodkilde-Jorgensen H, Jorgensen TM, Knepper MA, Nielsen S, Djurhuus JC, Frokiaer J (2004) Early release of neonatal ureteral obstruction preserves renal function. Am J Physiol 286:F1087–F1099Google Scholar
  92. 92.
    Chevalier RL, Thornhill BA, Chang AY (2000) Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney Int 58:1987–1995PubMedGoogle Scholar
  93. 93.
    Fenghua W, Junjie S, Gaoyan D, Jiacong M (2009) Does intervention in utero preserve the obstructed kidneys of fetal lambs? A histological, cytological, and molecular study. Pediatr Res 66:145–148PubMedGoogle Scholar
  94. 94.
    Hughson MD, Farris AB, Douglas-Denton R, Hoy WE, Bertram JF (2003) Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63:2113–2122PubMedGoogle Scholar
  95. 95.
    Hoy WE, Rees M, Kile E, Mathews JD, Wang Z (1999) A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int 56:1072–1077PubMedGoogle Scholar
  96. 96.
    Luyckx VA, Brenner BM (2005) Low birth weight, nephron number, and kidney disease. Kidney Int 68:S68–S77Google Scholar
  97. 97.
    Elder JS, Stansbrey R, Dahms BB, Selzman AA (1995) Renal histological changes secondary to ureteropelvic junction obstruction. J Urol 154:719–722PubMedGoogle Scholar
  98. 98.
    Stock JA, Krous HF, Heffernan J, Packer M, Kaplan GW (1995) Correlation of renal biopsy and radionuclide renal scan differential function in patients with unilateral ureteropelvic junction obstruction. J Urol 154:716–718PubMedGoogle Scholar
  99. 99.
    Pascual L, Oliva J, Vega J, Principi I, Valles P (1998) Renal histology in ureteropelvic junction obstruction: are histological changes a consequence of hyperfiltration? J Urol 160:976–979PubMedGoogle Scholar
  100. 100.
    Zhang PL, Peters CA, Rosen S (2000) Ureteropelvic junction obstruction: morphological and clinical studies. Pediatr Nephrol 14:820–826PubMedGoogle Scholar
  101. 101.
    Roth KS, Carter WH Jr, Chan JCM (2001) Obstructive nephropathy in children: long-term progression after relief of posterior urethral valve. Pediatrics 107:1004–1010PubMedGoogle Scholar
  102. 102.
    Biard JM, Johnson MP, Carr MC, Wilson RD, Hedrick HL, Pavlock C, Adzick NS (2005) Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet Gynecol 106:503–508PubMedGoogle Scholar
  103. 103.
    Edouga D, Hugueny B, Gasser B, Bussières L, Laborde K (2001) Recovery after relief of fetal urinary obstruction: morphological, functional and molecular aspects. Am J Physiol 281:F26–F37Google Scholar
  104. 104.
    Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K (2005) Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol 16:2557–2564PubMedGoogle Scholar
  105. 105.
    Peters CA (1995) Urinary tract obstruction in children. J Urol 154:1874–1883PubMedGoogle Scholar
  106. 106.
    Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95Google Scholar
  107. 107.
    Decramer S, Wittke S, Mischak H, Zurbig P, Walden M, Bouissou F, Bascands JL, Schanstra JP (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med 12:398–400PubMedGoogle Scholar
  108. 108.
    Zurbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL, Schanstra JP (2009) The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics 9:2108–2117PubMedGoogle Scholar
  109. 109.
    Lee RS, Monigatti FM, Lutchman M, Patterson T, Budnik B, Steen JAJ, Freeman MR, Steen H (2008) Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation. Proteomics 8:1097–1112PubMedGoogle Scholar
  110. 110.
    Furness PD III, Maizels M, Han SW, Cohn RA, Cheng EY (1999) Elevated bladder urine concentration of transforming growth factor-β1 correlates with upper urinary tract obstruction in children. J Urol 162:1033–1036PubMedGoogle Scholar
  111. 111.
    Yang SP, Woolf AS, Yuan HT, Scott RJ, Risdon RA, O'Hare MJ, Winyard PJD (2000) Potential biological role of transforming growth factor-β1 in human congenital kidney malformations. Am J Pathol 157:1633–1647PubMedGoogle Scholar
  112. 112.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP (2000) MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 58:182–192PubMedGoogle Scholar
  113. 113.
    Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P (2006) The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 69:1189–1197PubMedGoogle Scholar
  114. 114.
    Guron G, Friberg P (2000) An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123–137PubMedGoogle Scholar
  115. 115.
    Kagami S, Border WA, Miller DE, Noble NA (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-Beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431–2437PubMedGoogle Scholar
  116. 116.
    Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, Belingheri M, Avolio L, Ciofani A, Claris-Appiani A, Cusi D, Edefonti A, Ammenti A, Cecconi M, Fede C, Ghio L, La Manna A, Maringhini S, Papalia T, Pela I, Pisanello L, Ratsch IM (2007) No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy—report from the ItalKid project database. Nephrol Dial Transplant 22:2525–2530PubMedGoogle Scholar
  117. 117.
    Chevalier RL, Goyal S, Thornhill BA (1999) EGF improves recovery following relief of unilateral ureteral obstruction in the neonatal rat. J Urol 162:1532–1536PubMedGoogle Scholar
  118. 118.
    Chevalier RL, Goyal S, Kim A, Chang AY, Landau D, LeRoith D (2000) Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int 57:882–890PubMedGoogle Scholar
  119. 119.
    Fogo AB (2003) The potential for regression of renal scarring. Curr Opin Nephrol Hypertens 12:223–225PubMedGoogle Scholar
  120. 120.
    Eddy AA (2005) Can renal fibrosis be reversed? Pediatr Nephrol 20:1369–1375PubMedGoogle Scholar
  121. 121.
    Yoo KH, Thornhill BA, Forbes MS, Coleman CM, Marcinko ES, Liaw L, Chevalier RL (2006) Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int 70:1735–1741PubMedGoogle Scholar

Copyright information

© IPNA 2009

Authors and Affiliations

  • Robert L. Chevalier
    • 1
    • 2
    Email author
  • Barbara A. Thornhill
    • 1
  • Michael S. Forbes
    • 1
  • Susan C. Kiley
    • 1
  1. 1.Department of PediatricsUniversity of VirginiaCharlottesvilleUSA
  2. 2.Department of PediatricsUniversity of Virginia Health SystemCharlottesvilleUSA

Personalised recommendations